Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd)

Patrick J Hrdlicka, Jan S Jepsen, Claus Nielsen, Jesper Wengel, Jan Stenvang

    26 Citationer (Scopus)

    Abstract

    A series of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd) were designed to overcome the strict substrate specificity of the activating uridine-cytidine kinase. EUrd, ECyd and target nucleosides were obtained using a short convergent synthetic route utilizing diacetone-alpha-D-glucose as starting material. 5-Iodo-substituted EUrd was the most potent inhibitor among the novel nucleobase-modified analogs in in vitro assays against human adenocarcinoma breast and prostate cancer cells with IC50 values down to 35 nM.
    OriginalsprogEngelsk
    TidsskriftBioorganic & Medicinal Chemistry
    Vol/bind13
    Udgave nummer4
    Sider (fra-til)1249-60
    Antal sider12
    ISSN0968-0896
    DOI
    StatusUdgivet - 15 feb. 2005

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd)'. Sammen danner de et unikt fingeraftryk.

    Citationsformater